While price cut cards can assist relieve the burden of large drug expenditures within the short-term, they do not address the systemic concerns driving up prescription price ranges while in the U.S. Broader policy variations could deal with the basis triggers of increasing drug costs, such as insufficient transparency in pricing as well as the posi… Read More